Actively Recruiting
Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.
Led by AstraZeneca · Updated on 2026-04-29
218
Participants Needed
19
Research Sites
143 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an observational, multicenter, prospective study on patients with systemic lupus erythematosus treated with anifrolumab in Italy aimed at evaluating the achievement of LLDAS5
CONDITIONS
Official Title
Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provided informed consent to participate in the study
- Aged 18 years or older
- Fulfilled the 2019 EULAR/ACR classification criteria for SLE at the time of study entry
- Prescribed anifrolumab for SLE treatment for the first time according to approved Italian label and reimbursement criteria
You will not qualify if you...
- Patients who are at LLDAS5 at the time of study entry
- Previous exposure to anifrolumab
- Documented diagnosis of severe or rapidly progressive Class III or IV glomerulonephritis requiring induction therapy (mycophenolate mofetil or cyclophosphamide plus high dose steroids), isolated Class V lupus nephritis, or active severe or unstable neuropsychiatric lupus
- Currently participating in any interventional clinical trial with an investigational product
- Inability to understand and sign the informed consent and to fill in patient questionnaires
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 19 locations
1
Azienda Ospedaliero-Universitaria di Cagliari Presidio di Monserrato
Monserrato, CA, Italy, 09032
Not Yet Recruiting
2
Azienda Ospedaliero-Universitaria di Ferrara Arcispedale Sant'Anna
Cona, Ferrara, Italy, 44124
Actively Recruiting
3
IRCCS Humanitas Research Hospital
Rozzano, Milano, Italy, 20089
Not Yet Recruiting
4
AOU Ospedali Riuniti di Ancona - Presidio Torrette
Ancona, Italy, 60126
Not Yet Recruiting
5
Azienda Ospedaliero-Universitaria Policlinico di Bari
Bari, Italy, 70124
Not Yet Recruiting
6
ASST Spedali Civili di Brescia
Brescia, Italy, 25123
Not Yet Recruiting
7
Azienda Ospedaliero-Universitaria Careggi
Florence, Italy, 50134
Not Yet Recruiting
8
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy, 20122
Not Yet Recruiting
9
Policlinico di Modena - AOU di Modena
Modena, Italy, 41124
Not Yet Recruiting
10
Azienda Ospedaliera di Padova
Padova, Italy, 35128
Not Yet Recruiting
11
Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone"
Palermo, Italy, 90127
Not Yet Recruiting
12
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy, 27100
Not Yet Recruiting
13
Azienda Ospedaliero-Universitaria Pisana Ospedale Santa Chiara
Pisa, Italy, 56126
Not Yet Recruiting
14
Policlinico Tor Vergata
Roma, Italy, 00133
Not Yet Recruiting
15
Policlinico Umberto I - Sapienza Università di Roma
Roma, Italy, 00161
Not Yet Recruiting
16
Azienda Ospedaliera Ordine Mauriziano Umberto I
Torino, Italy, 10128
Not Yet Recruiting
17
Azienda Sanitaria Universitaria Giuliano Isontina (ASU GI) - Ospedale di Cattinara
Trieste, Italy, 34128
Not Yet Recruiting
18
ASU Friuli Centrale - Ospedale Santa Maria della Misericordia di Udine
Udine, Italy, 33100
Not Yet Recruiting
19
AOUI Verona - Ospedale Borgo Roma
Verona, Italy, 37134
Not Yet Recruiting
Research Team
A
AstraZeneca Clinical Study Information Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here